Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

TRENDING
Chinese Coffee Lovers Can Now Order Starbucks Through Alibaba’s Smart Speaker
Chinese Autonomous Truck Startup Raises $120 Million From UPS, Others
China to Release 10,000 Tons of Pork From Reserves Amid Short Supply
LATEST
World’s Highest Grid Project Takes Shape on ‘Roof of the World’
Battery Giant CATL in $1.4 Billion Fund-Raising Plan
Alibaba Recruits Big-Hitters for AI Research Labs
Zhejiang Regulators May Struggle to Implement Consumer Loan Rules
Is This Chinese Local Government Using a Journalist’s Trial to Quash Dissent?
ABB Bulks Up With Huawei on Industrial Cloud
China Biologic Receives $4.6 Billion Buyout Offer
Henlius Biotech Raises $410 Million in Hong Kong IPO
Mobile Game Revenue Steadily Recovering, Report Says
China’s Cybersecurity Industry Expected to Grow 23% to $8.9 Billion
Airbus to Launch On-Demand Helicopter Services in China’s Greater Bay Area
China Oil Giants Face Uncertainties After Saudi Attacks: Sources
Chinese Coffee Lovers Can Now Order Starbucks Through Alibaba’s Smart Speaker
Tencent, Xiaomi Discover Not All Buybacks Created Equal
Huawei Launches ‘World’s Fastest AI Training Cluster’
Huawei Executive Says U.S. Government Should Include Company in Trade Talks
China Spending on Planes and Services to Total $2 Trillion by 2038, Boeing Says
Chinese Autonomous Truck Startup Raises $120 Million From UPS, Others
China to Release 10,000 Tons of Pork From Reserves Amid Short Supply
Appliance Company’s Husband-and-Wife Executives Punished for Stock Price Manipulation
Company Dismisses Own Swine Fever Vaccine Claim as ‘Typo’

By Chen Shuning and Zhao Runhua / Jun 18, 2019 07:04 PM / Business & Tech

Photo: VCG

Photo: VCG

A Chinese pharmaceutical company has called its previous claim to be working on an African swine fever vaccine the result of a “typo” — after China’s agricultural ministry dismissed the “vaccine” as having “no scientific basis.”

The drama began last week, when Shenzhen-listed Guangdong Highsun Group said it was working with researchers to develop a vaccine that the company said could effectively “prevent and cure” the disease, which has ravaged China’s pork industry.

But the Ministry of Agriculture and Rural Affairs responded to Highsun’s claims with skepticism, saying the research team had failed to file applications for clinical trials of the alleged vaccine, and that there was no evidence to believe Highsun’s proposed solution would work.

On Monday, Highsun said an employee had made a “typo” when calling the drug a “vaccine” in an official announcement, and said it would like to “sincerely apologize” to any investors it had misled.

The clarification comes after the Shenzhen Stock Exchange asked Highsun to explain its research into the “vaccine,” after Highsun’s initial announcement caused its stock to surge for several days.

Related: Agriculture Ministry Rejects Claimed Swine Fever Vaccine Fix

Share this article
Open WeChat and scan the QR code